0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Incidence of Panic Disorder Diagnoses After Celebrity Disclosures of Panic Disorder in South Korea

      research-article
      , MD, PhD 1 , , MD, PhD 2 , , , PhD 3 , , MD, PhD 4 , , MD, PhD 5 ,
      JAMA Network Open
      American Medical Association

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Key Points

          Question

          How do celebrity disclosures of mental health conditions correlate with public attitudes and help-seeking behavior for these conditions in a population?

          Findings

          In this cohort study, there was a significant and sustained increase in both the incidence and prevalence of panic disorder diagnoses in South Korea following the public disclosure of panic disorder diagnoses by 3 high-profile Korean celebrities between December 2010 and January 2012, as evidenced by insurance claims data. Internet searches for the condition surged during this period.

          Meaning

          These results suggest that celebrity disclosures are associated with immediate and lasting reductions in stigma around mental health conditions, as reflected in increased help-seeking behavior, and may positively influence public attitudes toward mental health conditions for more than a decade.

          Abstract

          This cohort study of national claims data in South Korea examines the association of panic disorder diagnoses and related internet search traffic with 3 public disclosures of panic disorder diagnosis by celebrities.

          Abstract

          Importance

          The persistent stigma associated with mental health conditions is a major challenge worldwide. Celebrities may improve this by openly discussing their own mental health issues, potentially influencing public attitudes and encouraging individuals to seek treatment for these conditions.

          Objective

          To evaluate the impact of celebrity mental health disclosures on the incidence and prevalence of panic disorder diagnosis in South Korea.

          Design, Setting, and Participants

          This cohort study included the entire South Korean population from January 2004 to December 2021, as reflected in the National Health Insurance Service data. Analysis was conducted from May 2022 through January 2024.

          Exposure

          Time periods analyzed included the timeframe before (from January 2004 to December 2010) and after the public disclosures of panic disorder by 3 high-profile Korean celebrities between December 2010 and January 2012 (from January 2011 to December 2021).

          Main Outcomes and Measures

          Monthly incidence and prevalence of panic disorder, defined by the presence of a clinical diagnosis of the condition. Trends were assessed using interrupted time series analysis with autoregressive integrated moving average models. To assess public interest in panic disorder, trends in search data were analyzed, examining the association between the timing of increased searches and changes in the incidence and prevalence of panic disorder. Data on obsessive-compulsive disorder (OCD) were included as a control.

          Results

          The study covered the entire population of South Korea, including 48 559 946 individuals in January 2004 and 52 593 886 individuals in December 2021. Before 2011, the mean (SD) annual prevalence of panic disorder was stable at 560 (140) persons per 100 000 persons per year. The celebrity disclosure in December 2010 was associated with higher monthly incidence rates of panic disorder, as measured by insurance claims data, changes that were observed in both the level (5.8 persons; 95% CI, 2.2-9.5 persons) and slope (0.78 persons per month; 95% CI, 0.19-1.40 persons per month) per 100 000 persons. By 2021, the observed annual prevalence per 100 000 persons reached 7530 persons, an increase of 775.6% compared with the 860 persons (95% CI, 330-1400 persons) estimated if the disclosures had not occurred. Internet searches anticipated changes in monthly prevalence with a lag of 2 or 3 months (F = 4.26, P = .02 and F = 3.11, P = .03, respectively). The celebrity disclosures had no significant association with the incidence or prevalence of OCD.

          Conclusions and Relevance

          In this observational cohort study, celebrity disclosure of mental health conditions was associated with a sustained reduction in stigma, as reflected in increased help-seeking behavior for the condition over more than a decade. This underscores the influential role celebrities can play in shaping public health perceptions and behaviors, offering valuable insights for the development of future mental health policies and public awareness campaigns.

          Related collections

          Most cited references41

          • Record: found
          • Abstract: found
          • Article: not found

          Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

          Little is known about lifetime prevalence or age of onset of DSM-IV disorders. To estimate lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the recently completed National Comorbidity Survey Replication. Nationally representative face-to-face household survey conducted between February 2001 and April 2003 using the fully structured World Health Organization World Mental Health Survey version of the Composite International Diagnostic Interview. Nine thousand two hundred eighty-two English-speaking respondents aged 18 years and older. Lifetime DSM-IV anxiety, mood, impulse-control, and substance use disorders. Lifetime prevalence estimates are as follows: anxiety disorders, 28.8%; mood disorders, 20.8%; impulse-control disorders, 24.8%; substance use disorders, 14.6%; any disorder, 46.4%. Median age of onset is much earlier for anxiety (11 years) and impulse-control (11 years) disorders than for substance use (20 years) and mood (30 years) disorders. Half of all lifetime cases start by age 14 years and three fourths by age 24 years. Later onsets are mostly of comorbid conditions, with estimated lifetime risk of any disorder at age 75 years (50.8%) only slightly higher than observed lifetime prevalence (46.4%). Lifetime prevalence estimates are higher in recent cohorts than in earlier cohorts and have fairly stable intercohort differences across the life course that vary in substantively plausible ways among sociodemographic subgroups. About half of Americans will meet the criteria for a DSM-IV disorder sometime in their life, with first onset usually in childhood or adolescence. Interventions aimed at prevention or early treatment need to focus on youth.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            What is the impact of mental health-related stigma on help-seeking? A systematic review of quantitative and qualitative studies

            Psychological Medicine, 45(1), 11-27
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Evidence for effective interventions to reduce mental-health-related stigma and discrimination.

              Stigma and discrimination in relation to mental illnesses have been described as having worse consequences than the conditions themselves. Most medical literature in this area of research has been descriptive and has focused on attitudes towards people with mental illness rather than on interventions to reduce stigma. In this narrative Review, we summarise what is known globally from published systematic reviews and primary data on effective interventions intended to reduce mental-illness-related stigma or discrimination. The main findings emerging from this narrative overview are that: (1) at the population level there is a fairly consistent pattern of short-term benefits for positive attitude change, and some lesser evidence for knowledge improvement; (2) for people with mental illness, some group-level anti-stigma inventions show promise and merit further assessment; (3) for specific target groups, such as students, social-contact-based interventions usually achieve short-term (but less clearly long-term) attitudinal improvements, and less often produce knowledge gains; (4) this is a heterogeneous field of study with few strong study designs with large sample sizes; (5) research from low-income and middle-income countries is conspicuous by its relative absence; (6) caution needs to be exercised in not overgeneralising lessons from one target group to another; (7) there is a clear need for studies with longer-term follow-up to assess whether initial gains are sustained or attenuated, and whether booster doses of the intervention are needed to maintain progress; (8) few studies in any part of the world have focused on either the service user's perspective of stigma and discrimination or on the behaviour domain of behavioural change, either by people with or without mental illness in the complex processes of stigmatisation. We found that social contact is the most effective type of intervention to improve stigma-related knowledge and attitudes in the short term. However, the evidence for longer-term benefit of such social contact to reduce stigma is weak. In view of the magnitude of challenges that result from mental health stigma and discrimination, a concerted effort is needed to fund methodologically strong research that will provide robust evidence to support decisions on investment in interventions to reduce stigma.
                Bookmark

                Author and article information

                Journal
                JAMA Netw Open
                JAMA Netw Open
                JAMA Network Open
                American Medical Association
                2574-3805
                10 July 2024
                July 2024
                10 July 2024
                : 7
                : 7
                : e2420934
                Affiliations
                [1 ]Department of Psychiatry, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Korea
                [2 ]Department of Preventive Medicine, University of Ulsan College of Medicine, Seoul, Korea
                [3 ]Department of Big Data Strategy, National Health Insurance Service, Wonju, Korea
                [4 ]Department of Preventive Medicine, Korea University College of Medicine, Seoul, Korea
                [5 ]Department of Psychiatry, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, Korea
                Author notes
                Article Information
                Accepted for Publication: May 7, 2024.
                Published: July 10, 2024. doi:10.1001/jamanetworkopen.2024.20934
                Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2024 Kim GE et al. JAMA Network Open.
                Corresponding Authors: Yong-Wook Shin, MD, PhD, Department of Psychiatry ( shaman@ 123456amc.seoul.kr ), and Min-Woo Jo, MD, PhD, Department of Preventive Medicine ( mdjominwoo@ 123456gmail.com ), University of Ulsan College of Medicine, 88 Olympicro-43gil, Songpa-gu, Seoul 05505, Korea.
                Author Contributions: Dr Shin had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
                Concept and design: Jo, Yoon, Shin.
                Acquisition, analysis, or interpretation of data: G. E. Kim, Jo, Y. E. Kim, Shin.
                Drafting of the manuscript: G. E. Kim, Shin.
                Critical review of the manuscript for important intellectual content: All authors.
                Statistical analysis: Y. E. Kim, Shin.
                Obtained funding: Jo, Yoon.
                Administrative, technical, or material support: G. E. Kim, Jo.
                Supervision: Jo, Yoon, Shin.
                Conflict of Interest Disclosures: Dr Jo reported nonfinancial support from National Health Insurance Services during the conduct of the study; he reported grants from Ministry of Health and Welfare and Health Insurance Review & Assessment Service outside the submitted work. No other disclosures were reported.
                Funding/Support: This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea (grant No. HI18C0446). In addition, this study was administratively supported by the National Health Insurance Service of Korea (NHIS-2019-1-182).
                Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
                Data Sharing Statement: See Supplement 2.
                Article
                zoi240670
                10.1001/jamanetworkopen.2024.20934
                11238026
                38985471
                8eb2564b-87e0-4e80-9796-4a317e1430b6
                Copyright 2024 Kim GE et al. JAMA Network Open.

                This is an open access article distributed under the terms of the CC-BY License.

                History
                : 6 February 2024
                : 7 May 2024
                Categories
                Research
                Original Investigation
                Online Only
                Psychiatry

                Comments

                Comment on this article